GlassScriptPhysician profile
Erin Hodges
NPI 1942988431
$4,024.55
in general payments reported to CMS, 2019-2025
22 companies · $2,492 in 2025
The $2,492 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,532 · 2025: $2,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,024.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $627.48 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $517.78 | 2024-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.32 | 2024-2025 | Jardiance |
| Amgen INC. | $368.26 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $344.39 | 2024-2025 | Verquvo |
| Medtronic, INC. | $246.71 | 2025 | Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Inspire Medical Systems, INC. | $236.22 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $190.53 | 2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $171.22 | 2025 | |
| Pfizer INC. | $141.11 | 2024-2025 | |
| Boston Scientific Corporation | $134.65 | 2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $134.51 | 2024-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $114.14 | 2024-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $95.03 | 2024 | Xarelto |
| Bridgebio Pharma, INC. | $69.27 | 2025 | Attruby |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $56.12 | 2025 | Evkeeza |
| Esperion Therapeutics, INC. | $50.31 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $38.05 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.24 | 2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $30.54 | 2024 | |
| Abiomed | $25.30 | 2025 | |
| Atricure, INC. | $19.37 | 2025 | Synergy Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.